A comparative evaluation of commercially available cell-based allografts in a rat spinal fusion model

B Johnstone, N Zhang, EI Waldorff… - International Journal of …, 2020 - ijssurgery.com
Background: To evaluate the comparative abilities of commercially available, viable, cellular
bone allografts to promote posterolateral spinal fusion. Methods: Human allografts …

Comparing cellular bone matrices for posterolateral spinal fusion in a rat model

C Lin, N Zhang, EI Waldorff, P Punsalan, D Wang… - JOR …, 2020 - Wiley Online Library
Introduction Cellular bone matrices (CBM) are allograft products that provide three
components essential to new bone formation: an osteoconductive scaffold, extracellular …

Comparing cellular bone matrices for posterolateral spinal fusion

B Johnstone, J Ryaby, N Zhang… - Orthopaedic …, 2020 - boneandjoint.org.uk
The range of allograft products for spinal fusion has been extended with the development of
cellular bone matrices (CBMs). Most of these combine demineralized bone with viable …

Evaluation of posterolateral spinal fusion using mesenchymal stem cells: differences with or without osteogenic differentiation

T Nakajima, H Iizuka, S Tsutsumi, M Kayakabe… - Spine, 2007 - journals.lww.com
Study Design. An animal study to achieve posterolateral intertransverse process spine
fusion using mesenchymal stem cell (MSC). Objective. We investigated the effectiveness of …

Tissue engineered bone differentiated from human adipose derived stem cells inhibit posterolateral fusion in an athymic rat model

C Saifi, J Bernhard, JN Shillingford, P Petridis… - Spine, 2018 - journals.lww.com
Study Design. Biological augmentation spinal arthrodesis trial in athymic rats. Objective. To
assess the efficacy of tissue-engineered bone to promote L4-L5 intertransverse process …

Use of fluorescence labeled mesenchymal stem cells in pluronic F127 and porous hydroxyapatite as a bone substitute for posterolateral spinal fusion

WJ Chen, JW Huang, CC Niu, LH Chen… - Journal of …, 2009 - Wiley Online Library
Posterolateral spinal fusion is used to treat patients with degenerative spinal disorders. We
investigated the effectiveness of a mesenchymal stem cell (MSC)/Pluronic F127/Interpore …

Comparative efficacy of commonly available human bone graft substitutes as tested for posterolateral fusion in an athymic rat model

N Bhamb, LEA Kanim, S Drapeau, S Mohan… - International Journal of …, 2019 - ijssurgery.com
Background: Insufficient data exist on bone graft substitute materials efficacy; two thirds lack
any clinical data., This prospective animal study identified efficacy differences among …

Allogeneic mesenchymal progenitor cells for posterolateral lumbar spine fusion in sheep

DL Wheeler, JM Lane, HB Seim III, CM Puttlitz, S Itescu… - The Spine Journal, 2014 - Elsevier
Background context Osteoconductive porous ceramic bone graft materials supplemented
with mesenchymal precursor cells (MPC) derived from autologous bone marrow aspirates …

Genetically modified human derived bone marrow cells for posterolateral lumbar spine fusion in athymic rats: beyond conventional autologous bone grafting

B Peterson, R Iglesias, J Zhang, JC Wang… - Spine, 2005 - journals.lww.com
Study Design. This experimental study consisted of four groups. In Group I, 8 animals were
implanted with a collagen sponge containing 5 million human-derived bone marrow cells …

Posterolateral spinal fusion with ostegenesis induced BMSC seeded TCP/HA in a sheep model

BS Shamsul, KK Tan, HC Chen, BS Aminuddin… - Tissue and Cell, 2014 - Elsevier
Autogenous bone graft is the gold standard for fusion procedure. However, pain at donor
site and inconsistent outcome have left a surgeon to venture into some other technique for …